A Dose Finding Study of AEB071 Assessing Psoriasis Area and Severity Index in Patients With Plaque Psoriasis

NCT00885196 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

336

Enrollment

INDUSTRY

Sponsor class

Conditions

Moderate and Severe Plaque Psoriasis

Interventions

DRUG: Placebo
DRUG: AEB071

Sponsor

Novartis Pharmaceuticals